Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative study.

N, Viazis; M, Toruner; V, Papastergiou; K, Mousourakis; A, Christidou; M, Tzouvala; E, Zacharopoulou; M, Palatianou; G, Theocharis; G, Geramoutsos; A, Theodoropoulou; K, Karmiris; M, Velegraki; Çelik A, Ferhat; A, Akpinar; E, Zampeli; E, Papathanasiou; NG, Unal; A, Kapsoritakis; K, Argyriou; D, Christodoulou; K, Katsanos; F, Fousekis; T, Karakan; IE, Koutroubakis; I, Drygiannakis; O, Giouleme; M, Kalogirou; E, Vlachou; C, Liatsos; N, Kyriakos; E, Tsironi; P, Markopoulos; G, Bamias; K, Chalakatevaki; G, Tsiolakidou; C, Lamouri; G, Tribonias; K, Dimopoulou; P, Kasapidis; K, Paraskeva; P, Telli; F, Akyuz

doi:10.1097/meg.0000000000003083

Public

Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative study.

Shared by NobleBlocks on Nov 26, 2025 • 12:00 AM UTC

Authors:

Viazis N

Toruner M

Papastergiou V

Abstract

Objectives To identify the rate and predictors of successful antitumor necrosis factor (TNF) dose deescalation in patients with inflammatory bowel disease (IBD).Methods This multicenter retrospective cohort study collected data from consecutive IBD patients followed at referral centers in Greece and...

Subject

Ulcerative colitis

Inflammatory Bowel Disease

Crohn’s Disease

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!